SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
 
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Carestio Daniel A

(Last) (First) (Middle)
C/O 5960 HEISLEY ROAD

(Street)
MENTOR OH 44060

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
08/27/2015
3. Issuer Name and Ticker or Trading Symbol
STERIS CORP [ STE ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Sr. V. P., Isomedix & Life Sci
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Shares, No Par Value 23,951(1) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Option to Purchase Common Shares (2) 05/30/2022 Common Shares, No Par Value 2,225 29.94 D
Option to Purchase Common Shares (3) 05/31/2023 Common Shares, No Par Value 10,120 45.34 D
Option to Purchase Common Shares (4) 05/30/2024 Common Shares, No Par Value 7,000 53.52 D
Option to Purchase Common Shares (5) 08/10/2025 Common Shares, No Par Value 8,000 67.98 D
Explanation of Responses:
1. 16,800 of these Common Shares are restricted. The restrictions on these Common Shares lapse as follows: 4,500 on May 31, 2016; 3,300 on May 31, 2017; 4,000 on May 30, 2018; and 5,000 on May 28, 2019.
2. These will become exercisable as follows: 2,225 on May 30, 2016.
3. These options became or will become exercisable as follows: 2,530 on May 31, 2014; 2,530 on May 31, 2015; 2,530 on May 31, 2016 and 2,530 on May 31, 2017.
4. These options became or will become exercisable as follows: 1,750 on May 30, 2015; 1,750 on May 30, 2016; 1,750 on May 30, 2017 and 1,750 on May 30, 2018.
5. These options become exercisable as follows: 2,000 on May 28, 2016; 2,000 on May 28, 2017; 2,000 on May 28, 2018 and 2,000 on May 28, 2019.
Remarks:
/s/ Julia Kipnis, Authorized Representative under Power of Attorney 09/02/2015
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Securities and Exchange Commission Washington, D.C. 20549
RE:      STERIS Corporation
Commission File No. 1-14643
1933 Act and 1934 Act Filings

Authorized Representatives

Gentlemen:

The above Company is the issuer of securities registered under Section 12 of the

Securities Exchange Act of 1934. The person signing below confirms, as of the
date appearing opposite
his/her signature, that each of the "Authorized Representatives" named below is
authorized on his/her
behalf to sign such statements (on Form 3, Form 4, Form 5, Form 144, Schedule
13G, or otherwise)
with respect to securities of the Company (the "Securities"), and to submit to
the Securities and
Exchange Commission such filings (including reports, notices, and other
statements) with respect to
the Securities, as are required by the Securities Act of 1933, as amended, or
the Securities Exchange
Act of 1934 as amended (collectively, the "Acts"). The person so signing also
confirms the authority of
each of the Authorized Representatives to do and perform, on his/her behalf, any
and all acts and things
with respect to the Securities requisite or necessary to assure compliance by
the signing person with
the filing requirements of the Acts. This authority revokes all prior
authorities with respect to the
Securities previously executed by the person signing below including but not
limited to any such
authorities filed with or given to the Commission by the person signing below.
The authority confirmed
herein shall remain in effect as to the person signing below until such time as
the Commission shall
receive from that person a written communication that terminates or modifies the
authority.

Authorized Representatives

Judith A. Hunter
Julia Kipnis
Rebecca A. Nichols
Dennis P. Patton
Ronald E. Snyder
Michael J. Tokich
J. Adam Zangerle


Dated: August 26, 2015			By:  _/s/ Daniel A. Carestio____________________
						  Daniel A. Carestio

Shareholder Tools